Mis-splicing-derived neoantigens and cognate TCRsin splicing factor mutant leukemias00On 2025-05-012025-05-01By Bioinformatics Solutions IncIn Featured User Publications Effective immunotherapy for acute myeloid leukemia (AML) currently relies primarily on neoantigens derived from somatic mutations. However, these can sometimes...